CLEC4D and neoplasm: Moreover, the major bioactive compounds derived from P. cuspidatum may inhibit tumor development and destruction through the PI3K-AKT, JAK/STAT, MAPK, C-type lectin receptor signal pathways, and consistent with existing clinical reports [39–42], suggested that the KEGG pathway analysis results can be trusted.